Behind the Mystery of LGS on Lifetime TV

New Segment Airing Feb. 20th & 28th, 2023

“Rare Disease doesn’t come with a manual, it comes with a mother who never gives up!”

Tune in – February 20th & 28th, 2023

for a special Segment of Behind the Mystery

featuring LGS Foundation Executive Director,

Tracy Dixon-Salazar, PhD

Dr. Tracy Dixon-Salazar is a neuroscientist, geneticist, and patient advocate. Her desire to get her Ph.D. was inspired by her daughter, Savannah, who developed intractable seizures at the age of 2, which evolved into Lennox-Gastaut Syndrome (LGS) by the age of 5. She did her Ph.D. and postdoctoral work at UC, San Diego and it was during her research tenure, and after 16 years of watching daily, unrelenting seizures in her child, that she uncovered the driver of her daughter’s illness and identified a novel precision therapy that improved her child’s life.

Tracy now serves as the Executive Director at the LGS Foundation. She believes that patients must be involved in accelerating the research in LGS.

“Patient families are the experts on LGS and can help create meaningful, impactful, relevant, timely therapies when they are equal partners in research efforts.”

Details Coming Soon. 

Previously on Behind the Mystery of LGS:

A Mom’s Journey to Understand Her Daughter’s Rare Disease

Aired Monday, November 1, 2021

On International LGS Awareness Day (November 1), LGS Foundation Executive Director, Dr. Tracy Dixon-Salazar, and her daughter Savannah, who has LGS, shared their journey on a special episode of The Balancing Act airing on Lifetime TV.

Watch the Full Episode Here

These incredible Behind the Mystery of LGS segments were made possible with the generous support from our partners at:

About Behind the Mystery on Lifetime TV

A specialized, recurring segment devoted to rare and genetic diseases,Behind The Mystery highlights the emotional, scientific, and medical aspects associated with rare and genetic diseases. We clarify the often-complex issues by offering easy-to-understand explanations from top experts in the field. Our goal is to expand awareness for rare and genetic diseases through partnerships with pharmaceutical and biotech companies while giving voices to the patients, families, and advocates affected via our national television platform.


Donate now to help support our mission.


Updated 1/18/2023